Sprouts Farmers Market Faces Mounting Challenges as Sales Momentum Slows

Shares of Sprouts Farmers Market are under significant pressure following a stark reduction in the company's fourth-quarter outlook. The organic-focused grocer now anticipates comparable store sales growth of just 0% to 2%, a marked deceleration from its recent performance. This forecast lags behind key competitors and falls below the 2.4% food inflation rate recorded in December, signaling a potential loss of market traction.

The company attributed its tempered expectations to a confluence of challenges. These include difficult prior-year comparisons, emerging signs of softening consumer demand, and intensified competition within the natural and organic food sector. This represents a notable shift; as recently as the third quarter of 2025, Sprouts reported robust comparable sales growth of 5.9%, benefiting from sustained consumer interest in fresh, organic produce.

Compounding these operational concerns is a newly filed securities class action lawsuit. The litigation alleges the company made misleading statements to investors between June 4 and October 29, 2025, concerning the strength of its consumer base and its resilience to competitive and macroeconomic pressures. The deadline for lead plaintiff motions is January 26, 2026.

Should investors sell immediately? Or is it worth buying Sprouts Farmers Market?

Market Reaction and Analyst Sentiment

The market's reaction to the company's third-quarter earnings and reduced guidance was severe. On October 29, 2025, Sprouts' stock price plummeted intraday from $104.55 to $77.25—a single-day decline of 26.11%. The equity has continued to struggle, currently trading around $78.59. This reflects a loss of more than 56% from its peak of approximately $179.53 in June 2025.

Equity researchers have adopted a cautious stance. Deutsche Bank maintained a Hold rating on January 8, 2026, with an $88 price target, citing food disinflation and the reduction of government assistance programs as headwinds. Goldman Sachs had previously taken action in October, lowering its target to $152 from $178.

The Path Forward

All eyes are now on Sprouts' upcoming quarterly results for signs of stabilization or further weakness. Analysts suggest that comparable store sales growth consistently exceeding 2% would signal a recovery is taking hold. However, if performance remains within the guided 0% to 2% range, pressure on both revenue and the company's valuation is likely to persist. The pending class action adds a layer of legal uncertainty that may weigh on investor sentiment in the near term, making the next several earnings reports critical for the stock's trajectory.